Dominari Holdings Inc.
US ˙ NasdaqCM ˙ US0088753043

Introduction

This page provides a comprehensive analysis of the known insider trading history of Eric Weisblum. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Eric Weisblum has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:SILO / Silo Pharma, Inc. Chief Executive Officer, Director 197,932
US:SPEX / Spherix, Inc. Director 50,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Eric Weisblum. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases DOMH / Dominari Holdings Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in DOMH / Dominari Holdings Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DOMH / Dominari Holdings Inc. Insider Trades
Insider Sales DOMH / Dominari Holdings Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in DOMH / Dominari Holdings Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DOMH / Dominari Holdings Inc. Insider Trades
Insider Purchases SILO / Silo Pharma, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in DOMH / Dominari Holdings Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2025-05-27 SILO Weisblum Eric 10,000 0.4329 10,000 0.4329 4,329 65 0.7791 3,462 79.97
2024-12-13 SILO Weisblum Eric 2,500 0.8387 2,500 0.8387 2,097
2024-11-22 SILO Weisblum Eric 2,500 0.9000 2,500 0.9000 2,250
2024-11-20 SILO Weisblum Eric 2,500 0.9500 2,500 0.9500 2,375
2024-06-12 SILO Weisblum Eric 4,438 1.1100 4,438 1.1100 4,926
2024-06-11 SILO Weisblum Eric 562 1.0800 562 1.0800 607
2024-04-05 SILO Weisblum Eric 400 2.0300 400 2.0300 812
2024-04-04 SILO Weisblum Eric 600 1.9600 600 1.9600 1,176
2024-04-01 SILO Weisblum Eric 1,100 1.9100 1,100 1.9100 2,101
2024-03-28 SILO Weisblum Eric 3,408 1.9400 3,408 1.9400 6,612
2023-12-20 SILO Weisblum Eric 200 1.6100 200 1.6100 322
2023-12-19 SILO Weisblum Eric 500 1.6300 500 1.6300 815
2023-12-15 SILO Weisblum Eric 900 1.5200 900 1.5200 1,368
2023-12-14 SILO Weisblum Eric 200 1.5000 200 1.5000 300
2023-12-07 SILO Weisblum Eric 324 1.3600 324 1.3600 441
2023-12-06 SILO Weisblum Eric 76 1.3400 76 1.3400 102
2023-12-05 SILO Weisblum Eric 600 1.3900 600 1.3900 834
2023-11-30 SILO Weisblum Eric 1,000 1.5300 1,000 1.5300 1,530
2023-11-29 SILO Weisblum Eric 1,000 1.5700 1,000 1.5700 1,570
2023-11-27 SILO Weisblum Eric 250 1.7800 250 1.7800 445
2023-11-22 SILO Weisblum Eric 400 1.6800 400 1.6800 672
2023-11-21 SILO Weisblum Eric 300 1.5600 300 1.5600 468
2023-11-20 SILO Weisblum Eric 4,050 1.6000 4,050 1.6000 6,480
2023-11-17 SILO Weisblum Eric 1,800 1.5400 1,800 1.5400 2,772
2023-11-16 SILO Weisblum Eric 1,100 1.3300 1,100 1.3300 1,463
2023-05-18 SILO Weisblum Eric 500 2.1070 500 2.1070 1,054
2023-05-17 SILO Weisblum Eric 2,500 2.0600 2,500 2.0600 5,150
2022-12-20 SILO Weisblum Eric 130 2.7200 130 2.7200 354
2022-12-19 SILO Weisblum Eric 200 2.6815 200 2.6815 536
2022-12-14 SILO Weisblum Eric 263 3.1699 263 3.1699 834
2022-12-13 SILO Weisblum Eric 487 3.0676 487 3.0676 1,494
2022-06-17 SILO Weisblum Eric 13,080 0.1147 262 5.7350 1,500
2021-12-13 SILO Weisblum Eric 17,500 0.1377 350 6.8850 2,410
2021-12-10 SILO Weisblum Eric 5,000 0.1554 100 7.7700 777
2019-10-22 SILO Weisblum Eric 200 0.4500 4 22.5000 90
2019-10-15 SILO Weisblum Eric 200 0.3800 4 19.0000 76
2019-06-17 SILO Weisblum Eric 57,714 0.0020 1,154 0.1000 115

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SILO / Silo Pharma, Inc. Insider Trades
Insider Sales SILO / Silo Pharma, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in DOMH / Dominari Holdings Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SILO / Silo Pharma, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Eric Weisblum as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2025-05-28 2025-05-27 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 10,000 197,932 5.32 0.43 4,329 85,685
2024-12-16 2024-12-13 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 2,500 187,932 1.35 0.84 2,097 157,619
2024-11-22 2024-11-22 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 2,500 185,432 1.37 0.90 2,250 166,889
2024-11-22 2024-11-20 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 2,500 182,932 1.39 0.95 2,375 173,785
2024-06-13 2024-06-12 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 4,438 180,432 2.52 1.11 4,926 200,280
2024-06-13 2024-06-11 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 562 175,994 0.32 1.08 607 190,074
2024-04-08 2024-04-05 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 400 175,432 0.23 2.03 812 356,127
2024-04-08 2024-04-04 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 600 175,032 0.34 1.96 1,176 343,063
2024-04-01 2024-04-01 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 1,100 174,432 0.63 1.91 2,101 333,165
2024-04-01 2024-03-28 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 3,408 173,332 2.01 1.94 6,612 336,264
2023-12-21 2023-12-20 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 200 169,924 0.12 1.61 322 273,578
2023-12-21 2023-12-19 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 500 169,724 0.30 1.63 815 276,650
2023-12-18 2023-12-15 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 900 169,224 0.53 1.52 1,368 257,220
2023-12-18 2023-12-14 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 200 168,324 0.12 1.50 300 252,486
2023-12-07 2023-12-07 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 324 168,124 0.19 1.36 441 228,649
2023-12-07 2023-12-06 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 76 167,800 0.05 1.34 102 224,852
2023-12-07 2023-12-05 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 600 167,724 0.36 1.39 834 233,136
2023-11-30 2023-11-30 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 1,000 167,124 0.60 1.53 1,530 255,700
2023-11-30 2023-11-29 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 1,000 166,124 0.61 1.57 1,570 260,815
2023-11-27 2023-11-27 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 250 165,124 0.15 1.78 445 293,921
2023-11-27 2023-11-22 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 400 164,874 0.24 1.68 672 276,988
2023-11-22 2023-11-21 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 300 164,474 0.18 1.56 468 256,579
2023-11-22 2023-11-20 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 4,050 164,174 2.53 1.60 6,480 262,678
2023-11-20 2023-11-17 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 1,800 160,124 1.14 1.54 2,772 246,591
2023-11-20 2023-11-16 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 1,100 158,324 0.70 1.33 1,463 210,571
2023-05-18 2023-05-18 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 500 157,724 0.32 2.11 1,054 332,324
2023-05-18 2023-05-17 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 2,500 157,224 1.62 2.06 5,150 323,881
2022-12-20 2022-12-20 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 130 154,854 0.08 2.72 354 421,203
2022-12-20 2022-12-19 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 200 154,724 0.13 2.68 536 414,892
2022-12-15 2022-12-14 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 263 154,524 0.17 3.17 834 489,826
2022-12-15 2022-12-13 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 487 154,261 0.32 3.07 1,494 473,211
2022-06-21 2022-06-17 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 13,080 7,724,643 0.17 0.11 1,500 886,017
2021-12-15 2021-12-13 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 17,500 7,711,563 0.23 0.14 2,410 1,061,882
2021-12-15 2021-12-10 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 5,000 7,694,063 0.07 0.16 777 1,195,657
2021-05-17 2019-10-22 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 200 58,114 0.35 0.45 90 26,151
2021-05-17 2019-10-15 4 SILO Silo Pharma, Inc.
Stock Option (right to buy) 		A - Award 100,000 100,000
2021-05-17 2019-10-15 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 200 57,914 0.35 0.38 76 22,007
2021-05-17 2019-06-17 4 SILO Silo Pharma, Inc.
Common Stock 		P - Purchase 57,714 57,714 0.00 115 115
2021-05-17 2019-04-15 4 SILO Silo Pharma, Inc.
Stock Option (right to buy) 		A - Award 100,000 100,000
2021-05-17 2019-04-15 4 SILO Silo Pharma, Inc.
Stock Option (right to buy) 		A - Award 100,000 100,000
2021-05-17 2020-04-28 4/A SILO Silo Pharma, Inc.
Common Stock 		A - Award 7,630,949 7,689,063 13,131.00
2020-04-30 2020-04-17 4 UCUT Uppercut Brands, Inc.
Common Stock 		A - Award 7,630,949 7,988,663 2,133.25
2018-02-20 2018-02-16 4 SPEX SPHERIX INC
Stock Option (right to buy) 		A - Award 50,000 50,000
2018-02-20 2018-02-16 4 SPEX SPHERIX INC
Common Stock, $.0001 par value per share 		A - Award 20,000 20,000
2017-06-07 2017-05-31 4 SPEX SPHERIX INC
Stock Option (right to buy) 		A - Award 3,947 3,948 394,700.00
2016-11-22 2016-08-24 4 SPEX SPHERIX INC
Stock Option (right to buy) 		A - Award 3,947 3,947
2014-09-04 2014-09-04 4 PTCI Point Capital, Inc.
Common Stock 		G - Gift -3,584,160 0 -100.00 1.00 -3,584,160
2014-08-01 2013-06-20 4 PTCI Point Capital, Inc.
Common Stock 		A - Award 3,584,160 3,584,160
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)